SNHG5 and cancer: Li et al. demonstrated that SNHG5 binding to UPF1 impairs its degradation activity, resulting in accumulation of β-catenin and Cyclin D1, thereby activating the Wnt/β-catenin pathway, maintaining cancer stemness, and promoting self-renewal [27].